S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The 4 highest-shorted large-cap stocks
The top-rated strong-buy stocks on Marketbeat’s radar
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What’s next for GM stock: Buybacks and a dividend increase
US economic growth for last quarter is revised up to a 5.2% annual rate
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The 4 highest-shorted large-cap stocks
The top-rated strong-buy stocks on Marketbeat’s radar
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What’s next for GM stock: Buybacks and a dividend increase
US economic growth for last quarter is revised up to a 5.2% annual rate
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The 4 highest-shorted large-cap stocks
The top-rated strong-buy stocks on Marketbeat’s radar
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What’s next for GM stock: Buybacks and a dividend increase
US economic growth for last quarter is revised up to a 5.2% annual rate
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The 4 highest-shorted large-cap stocks
The top-rated strong-buy stocks on Marketbeat’s radar
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What’s next for GM stock: Buybacks and a dividend increase
US economic growth for last quarter is revised up to a 5.2% annual rate

Kensington Capital Acquisition Corp. II Stock Price, News & Analysis (NYSE:KCAC)

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$8.30
$10.00
50-Day Range
$8.07
$10.00
52-Week Range
$7.28
$10.65
Volume
410,743 shs
Average Volume
185,002 shs
Market Capitalization
$247.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Kensington Capital Acquisition Corp. II

Kensington Capital Acquisition Corp. II focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2021 and is based in Westbury, New York.


KCAC Stock News Headlines

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
8-K: Kensington Capital Acquisition Corp. IV
Kensington Capital Acquisition Corp. II Class A News
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Wallbox to Trade on NYSE Under Ticker “WBX”
EV charging company Wallbox goes public via SPAC
Kensington Capital Acquisition Corp (KCAC_u)
See More Headlines
Receive KCAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kensington Capital Acquisition Corp. II and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
11/30/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Holding & Other Investment Offices
Sub-Industry
N/A
Sector
N/A
Phone
N/A
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$247.25 million
Optionable
Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Justin Mirro (Age 52)
    CEO & Chairman
  • Mr. Robert J. Remenar (Age 66)
    Vice Chairman & Pres
  • Mr. Daniel Huber (Age 45)
    CFO & Sec.
  • Mr. Simon Boag (Age 55)
    Chief Technology Officer














KCAC Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Kensington Capital Acquisition Corp. II own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kensington Capital Acquisition Corp. II investors own include Workhorse Group (WKHS), Social Capital Hedosophia Holdings Corp. II (IPOB), NIO (NIO), Sorrento Therapeutics (SRNE), Zynga (ZNGA), Walt Disney (DIS), Tesla (TSLA), DraftKings (DKNG), NVIDIA (NVDA) and Tortoise Acquisition (SHLL).

This page (NYSE:KCAC) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -